Harfst & Associates’s Avanos Medical AVNS Stock Holding History

Harfst & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12	Closed	–	–	285
2015 Q2	$0	Buy	+12	New	+$539	﹤0.01%	325

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Harfst & Associates's AVNS Position: Q3 2015 in Review

Harfst & Associates sold out of Avanos Medical (AVNS) in Q3 2015, closing a stake of 12 shares.

Harfst & Associates first reported a position in AVNS in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 353 funds tracked by Wall St. Rank hold AVNS as of Q3 2015.

Harfst & Associates reported no remaining Avanos Medical position as of Q3 2015 after selling out during the quarter.
Harfst & Associates sold 12 Avanos Medical shares in Q3 2015.
Harfst & Associates first reported a position in Avanos Medical in Q2 2015 and held it in 1 quarter.
Harfst & Associates's Avanos Medical position peaked at $0 in Q2 2015.
353 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2015.

Based on Harfst & Associates's 13F filing for Q3 2015, filed 9 Nov 2015.